SOLI - Solithromycin Pediatric Development Program (Phase 2/3)- Labor & Sub Cost
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
Cempra Pharmaceuticals, Inc.
Start Date
February 29, 2016
End Date
October 31, 2018
Administered By
Duke Clinical Research Institute
Awarded By
Cempra Pharmaceuticals, Inc.
Start Date
February 29, 2016
End Date
October 31, 2018